![Mark Bruzzi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Mark Bruzzi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vetex Medical Ltd.
![]() Vetex Medical Ltd. Medical SpecialtiesHealth Technology Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million. | Amministratore Delegato | - | - |
Fondatore | - | - |
Storia della carriera di Mark Bruzzi
Statistiche
Distribuzione geografica
Irlanda | 2 |
Posizioni
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Vetex Medical Ltd.
![]() Vetex Medical Ltd. Medical SpecialtiesHealth Technology Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million. | Health Technology |
- Borsa valori
- Insiders
- Mark Bruzzi
- Esperienza